During the past decade, SIH Cancer Institute conducted 135 clinical trials. In the 10-year time frame, 135 clinical trials started and 33 clinical trials were completed, i.e. on average, 24.4% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 31 clinical trials were completed. i.e. 75.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SIH Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 70 trials, followed by "Alliance for Clinical Trials in Oncology" with 30 trials sponsored, "SWOG Cancer Research Network" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "NRG Oncology" with 18 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SIH Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 89 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "SIH Cancer Institute" are "Invasive Breast Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Metastatic Malignant Neoplasm in the Brain" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials) and "Stage IIIA Breast Cancer" (5 trials). Many other conditions were trialed in "SIH Cancer Institute" in a lesser frequency.

Most popular intervention types in "SIH Cancer Institute" are "Drug" (120 trials), "Other" (87 trials), "Biological" (65 trials), "Procedure" (56 trials) and "Radiation" (22 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (36 trials), "Biospecimen Collection" (33 trials), "Computed Tomography" (33 trials), "Questionnaire Administration" (31 trials) and "Laboratory Biomarker Analysis" (30 trials). Other intervention names were less common.

The vast majority of trials in "SIH Cancer Institute" are 140 trials for "All" genders, 16 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "SIH Cancer Institute". undefined are not yet recruiting, 66 are recruiting, 71 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in SIH Cancer Institute, 6 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in SIH Cancer Institute, 5 "Phase 1" clinical trials were conducted, 81 "Phase 2" clinical trials and 72 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".